Deal for Kelonia Therapeutics could come as soon as Monday.

A deal could be reached as soon as Monday and could include additional payments tied to Kelonia meeting certain milestones, ...

Eli Lilly is in talks to buy Kelonia Therapeutics for $2B+, boosting its oncology pipeline with next-gen CAR-T for multiple ...

Can Eli Lilly (NYSE: LLY) stock surge 2x to $2,000 in the coming years? We believe that this is indeed a genuine possibility.

Foundayo was approved in the U.S. on April 1, with prescriptions accepted immediately on LillyDirect, while shipping started ...

The company's recent dip may be a buying opportunity.

This article considers whether Eli Lilly, at around US$927 per share, is still priced for opportunity or already reflects ...

Eli Lilly and Indiana are partnering to explore and deploy nuclear energy options to Indiana's grid.

By Sriparna Roy April 17 (Reuters) - Eli Lilly's newly launched weight-loss pill was prescribed 1,390 times in the U.S. in ...

Eli Lilly and Company (NYSE:LLY) is one of the 10 Best Stocks to Buy for the Next Decade.

The trial of 2,700 patients with increased cardiovascular risk showed that Foundayo lowered ‌the risk of heart attack, stroke ...

Lilly plans to file Foundayo with the FDA for type 2 diabetes by end of Q2 after the ACHIEVE-4 trial met its primary ...